Abstract
Amphetamine psychosis is at times strikingly similar to paranoid schizophrenia. How closely the exogenous model fits the endogenous psychosis is of vital interest. If such a model is valid, it would have great potential for explaining paranoid schizophrenia. This chapter presents a review of the strengths and weaknesses of amphetamine psychosis as a model for paranoid schizophrenia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anggard, E., Jonsson, L.-E., Hogmark, A.-L., and Grunne, L.-M., 1973, Amphetamine metabolism in amphetamine psychosis, Clin. Pharmacol. Ther. 14(5):870–880.
Angrist, B. M., Shopsin, B., and Gershon, S., 1971, Comparative psychotomimetic effects of stereoisomers of amphetamine, Nature, (London) 234:152–153.
Angrist, B., Shopsin, B., and Gershon, S., 1972, Metabolites of monamines in urine and cerebrospinal fluid, after large dose amphetamine administration, Psychopharmacologia (Berlin) 26:1–9.
Axelrod, J., 1972, Biogenic amines and their impact in psychiatry, Semin. Psychiatry 4(3): 199–210.
Bell, D. S., 1965, Comparison of amphetamine psychosis and schizophrenia, Br. J. of Psychiatry 111:701–707.
Bell, D. S., 1973, The experimental reproduction of amphetamine psychosis, Arch. Gen. Psychiatry 29:35–40.
Benakis, A., and Thomasset, M., 1970, Metabolism of amphetamines and their interaction with barbiturates and SKF-525A, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 153–164, Raven Press, New York.
Bradley, C., 1937, The behavior of children receiving Benzedrine, Am. J. Psychiatry 94:577–585.
Cameron, N., 1959, Paranoid conditions and paranoia, in: American Handbook of Psychiatry (S. Arieti, ed.), Vol. 1, p. 510, Basic Books, New York.
Cameron, N., 1963, Personality Development and Psychopathology-A Dynamic Approach, p. 475, Houghton Mifflin Co., Boston.
Cameron, N. A., 1967, Psychotic disorders. II. Paranoid reactions, in: Comprehensive Textbook of Psychiatry (Alfred M. Freedman and Harold I. Kaplan, eds.), p. 666, Williams & Wilkins Co., Baltimore.
Chapman, A. H., 1954, Paranoid psychosis associated with amphetamine usage: A clinical note, Am. J. Psychiatry 111:43.
Connell, P. H., 1958, Amphetamine Psychosis, Chapman and Hall, London.
Costall, B., Naylor, R. J., and Wright, T., 1972, The use of amphetamine-induced stereotyped behavior as a model for the experimental evaluation of antiparkinson agents, Arzneim.-Forsch. 22(7): 1178–1183.
Coyle, J. T., and Snyder, S. H., 1969, Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas, J. Pharmacol. Exp. Ther. 170:221–231.
Creese, I., and Iversen, S. D., 1975, The pharmacological and anatomical substrates of the amphetamine response in the rat, Brain Res. 83:419–436.
Deffenu, G., Bartolini, A., and Pepeu, G., 1970, Effect of amphetamine on cholinergic systems of the cerebral cortex of the cat, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 357–368, Raven Press, New York.
Delay, J., Pichot, P., Lemperiere, T., and Sadown, R., 1954, Ann. Med-Psychol. 112(2):51.
DSM-II (Diagnostic and Statistical Manual of Mental Disorders), 1968, 2nd Ed., American Psychiatric Association, Washington, D.C.
Ellinwood, E. H., Jr., 1967, Amphetamine psychosis. 1. Description of the individuals and process, J. Nerv. Ment. Dis. 144:273–283.
Ellinwood, E. H., Jr., 1972, Amphetamine psychosis: Individuals, settings, and sequences, in: Current Concepts on Amphetamine Abuse (E. H. Ellinwood and S. Cohen, eds.), p. 144, National Institute of Mental Health, Rockville, Maryland.
Ellinwood, E. H., Jr., Sudilovsky, A., Nelson, L. M., 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am. J. Psychiatry 130(10): 1088–1093.
Ferris, R. M., Tang, F. L. M., Maxwell, R. A., 1972, A comparison of the capabilities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into the adrenergic nerves of the rabbit aorta, J. Pharmacol. Exp. Ther. 181:407–416.
Fisher, E., Spatz, H., Saavedra, M., Reggiani, H., Miro, A. H., and Heller, B., 1972, Urinary elimation of phenylethylamine, Biol. Psychiatry 5(2): 139–147.
Frey, H. H., 1970, p-Chloroamphetamine-similarities and dissimilarities to amphetamine, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), p. 343, Raven Press, New York.
Fuxe, K., and Ungerstedt, U., 1968, Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine, Eur. J. Pharmacol. 4:135–144.
Gillin, J. C., Kaplan, J., Stillman, R. C., and Wyatt, R. J., 1976, The psychedelic model of schizophrenia: The case of N,N-dimethyl-tryptamine (DMT), Am. J. Psychiatry 133:203–208.
Goodwin, D. W., Alderson, P., and Rosenthal, R., 1971, Clinical significance of hallucinations in psychiatric disorders: A study of 116 hallucinatory patients, Arch. Gen. Psychiatry 24:76–80.
Griffith, J. D., Cavanaugh, J., Held, J., and Oates, J. A., 1970, Experimental psychosis induced by the administration of d-amphetamine, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 897–904, Raven Press, New York.
Griffith, J. D., Cavanaugh, J., Held, J., and Oates, J. A., 1972, Dextroamphetamine: Evaluation of psychotomimetic properties in man. Arch. Gen. Psychiatry 26:97–100.
Grunne, E., and Lewander, T., 1967, Long-term effects of some dependence-producing drugs on the brain monamines, in: Molecular Basis of Some Aspects of Mental Activity (O. Wahaas, ed.), Vol. 2, pp. 75–81, New York.
Harris, J. E., and Baldessarini, R. J., 1973, Uptake of [3H]catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues, Neuropharmacology 12:669–679.
Heikkila, R. E., Orlansky, H., Mytilineou, C., and Cohen, G., 1975, Amphetamine: Evaluation of d-and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex, J. Pharmacol. Exp. Ther. 194:47–56.
Himmelhoch, J. M., Detre, T., Kupfer, D. J., and Byck, R., 1972, Treatment of previously intractable depressions with tranylcypromine and lithium, J. Nerv. Ment. Dis. 155:216–220.
Hollister, L. E., 1968a, Human pharmacology of lysergic acid diethylamide (LSD), in: Psychopharmacology: A Review of Progress 1957–1967 (D. H. Efron, ed.), Public Health Service Publication 1836, pp. 1253–1261, U.S. Government Printing Office, Washington, D.C.
Hollister, L. E., 1968b, Chemical Psychoses, pp. 117–126, Charles C. Thomas, Springfield, Illinois.
Hornykiewicz, O., 1966, Dopamine 3-hydroxytryptamines and brain function, Pharmacol. Rev. 18(2):925–964.
Innes, I. R., and Nickerson, M., 1970, Amphetamine, in: The Pharmacological Basis of Therapeutics (Louis S. Goodman and Alfred Gilman, eds.), 3rd Ed., p. 501, Macmillan Co., New York.
Janowski, D. S., El-Yousef, K., Davis, J. M., Sekerke, H. J., 1973, Antagonist effects of physostigmine and methylphenidate in man, Am. J. Psychiatry 130(12): 1370–1376.
Kalant, O. J., 1966, The Amphetamines-Toxicity and Addiction, p. 53, Charles C. Thomas, Springfield, Illinois.
Kety, S. S., 1959, Biochemical theories of schizophrenia, Science 129:1–12.
Knoll, J., 1973, Modulation of learning and retention by amphatamines, in: Pharmacology and the Future of Man: Proceedings of the Fifth International Congress on Pharmacology, San Francisco 1972, Vol. 4, pp. 55–68, S. Karger, Basel.
Kramer, J. C., 1969, Introduction to amphetamine abuse, J. Psychedelic Drugs 11(2):1–16.
Layne, O. L., Jr., and Yudofsky, S. C., 1971, Postoperative psychosis in cardiotomy patients: Role of organic and psychiatric factors, N. Engl. J. Med. 284:518–520.
Lehmann, H. E., 1967, Schizophrenia: Clinical features, in: Comprehensive Textbook of Psychiatry (Alfred M. Freedman and Harold I. Kaplan, eds.), p. 629, Williams & Wilkins Co., Baltimore. Licit and Illicit Drugs, 1972 (Edward M. Brecher & the Editors of Consumers Reports eds.), Consumers Union, Mt. Vernon, New York.
Munkvad, I., Pakkenberg, H., and Randrup, A., 1968, Aminergic systems in basal ganglia associated with stereotyped behavior and catelepsy, Brain Behav. Evol. 1:89–100.
Nathanson, M. H., 1939, The central action of beta-amino-aminopropyl benzene (Benzedrine): Clinical observations, J. Am. Med. Assoc. 108:528–531.
Penn, H., Racy, J., Lapham, L., Mandel, M., and Sandt, J., 1972, Catatonic behavior, viral encephalopathy, and death, Arch. Gen. Psychiatry 27:758–761.
Post, R. M., 1973, Simulated behaviour states: An approach to specificity in psychobiological research, Biol. Psychiatry 7:237–254.
Prange, A. J., Wilson, I. C., Lynn, C. W., Allsop, L. B., and Stikeleather, R. A., 1974, l-Tryptophan in mania: Contribution to a permissive hypothesis of affective disorders, Arch. Gen. Psychiatry 30:56–62.
Prinzmetal, M., and Bloomberg, W., 1935, The use of Benzedrine for the treatment of narcolepsy, J. Am. Med. Assoc. 105:2051–2054.
Randrup, A., and Munkvad, I., 1967, Stereotyped activities produced by amphetamine in several animal species and man, Psychopharmacologia (Berlin) 11:300–310.
Randrup, A. and Munkvad, I., 1970, Biochemical, anatomical, and psychological investigations of stereotyped behavior induced by amphetamines, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 695–713, Raven Press, New York.
Rosenthal, D., 1970, Genetic Theory and Abnormal Behavior, McGraw-Hill, New York.
Ross, S. B., and Renyi, A.-L., 1975, Inhibition of uptake of 3H-dopamine and 14C-5-hydroxytryptamine in mouse striatum slices, Acta Pharmacol. Toxicol. 36:56–66.
Saavedra, J. M., 1974, Enzymatic isotopic assay for and presence of β-phenylethylamine in brain, J. of Neurochem. 22:211.
Schildkraut, J. J., 1969, Neuropsychopharmacology and the affective disorders, N. Engl. J. Med. 281:302–306.
Schildkraut, J. J., 1972, Neuropharmacologically generated models of the affective disorders: Biochemical versus behavioral models, Psychopharmacol. Bull. 8(3):61–62.
Schildkraut, J. J., and Kety, S. S., 1967, Biogenic amines and emotion, Science 156(3771):21–30.
Simpson, S. I., 1975, Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation, J. Pharmacol. Exp. Ther. 193:149–159.
Slater, E., 1959, Amphetamine psychosis, Br. Med. J. 1:488.
Snyder, S. H., 1972, Catecholamines in the brain as mediators of amphetamine psychosis, Arch. Gen. Psychiatry 27:169–179.
Stevens, J. R., 1973, An anatomy of schizophrenia?, Arch. Gen. Psychiatry 29:177–189.
Taylor, K. M., and Snyder, S. H., 1970, Amphetamine: Differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine, Science 168:1487–1489.
Thornburg, J. E., and Moore, K. E., 1973, Dopamine and norepinephrine uptake by rat brain synaptosomes: Relative inhibitory potencies of l-and d-amphetamine and amantadine, Res. Commun. Chem. Pathol. Pharmacol. 5:81–89.
Tsuang, M. T., and Winokur, G., 1974, Criteria for sub-typing schizophrenia: Clinical differentiation of hebephrenia and paranoid schizophrenia, Arch. Gen. Psychiatry 31:43–47.
Ungerstedt, U., 1971, Stereotaxic mapping of the monamine pathways in the rat brain, Acta Physiol. Scand. 367(Suppl.): 1–48.
Van Rossum, J. M., 1970, Mode of action of psychomotor stimulant drugs, Int. Rev. Neurobiol. 12:307–383.
Wallis, G. G., McHarg, J. F., and Scott, O. C. A., 1949, Acute psychosis caused by dextroamphetamine, Br. Med. J., 2:1394.
Waud, S. P., 1938, The effects of toxic doses of benzyl methyl carbinamine (Benzedrine) in man, J. Am. Med. Assoc. 110:206.
Welch, B. L., and Welch, A. S., 1970, Control of brain catecholamines and serotonin during acute stress and after d-amphetamine by natural inhibition of monamine-oxidase: An hypothesis, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 415–445, Raven Press, New York.
Wilson, I. C., Prange, A. J., Jr., and Laura, P. P., Methyltestosterone with imipramine in men: Conversion of depression to paranoid reaction, Am. J. Psychiatry 131(1): 21–24.
Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H., and Pollin, W., 1973, Reduced monamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia, Science 179:916–918.
Wyatt, R. J., Potkin, S. G., Gillin, J. C., and Murphy, D. L., 1977a, Enzymes involved in phenylethyalmine and catecholamine metabolism in schizophrenics and controls in: Psychopharmacology: A Review of Progress 1967–1976 (M. Lipton and A. DiMascio, eds.), Raven Press, New York (in press).
Wyatt, R. J., Gillin, J. C., Stoff, D. M., Moja, E. A., and Tinklenberg, J. R. 1977b, β- Phenylethylamine (PEA) and the neuropsychiatric disturbances, in: Neuroregulators and Psychiatric Disorders (E. Usdin, J. Barchas, and D. Hamburg, eds.), pp. 31–45, Oxford University Press. New York.
Young, D., and Scoville, W. B., 1938, Paranoid psychosis in narcolepsy and the possible danger of Benzedrine treatment, Med. Clin. North Am. 22:637–646.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Woodrow, K.M., Reifman, A., Wyatt, R.J. (1978). Amphetamine Psychosis—A Model for Paranoid Schizophrenia?. In: Haber, B., Aprison, M.H. (eds) Neuropharmacology and Behavior. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3961-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3961-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3963-2
Online ISBN: 978-1-4613-3961-8
eBook Packages: Springer Book Archive